<DOC>
	<DOCNO>NCT01663662</DOCNO>
	<brief_summary>It well know use loop diuretic acute set may decrease glomerular filtration rate ( GFR ) increase serum creatinine lead renal dysfunction . Loop diuretic induce elevation serum creatinine lead increase length hospital stay possibly morbidity . Previous study suggest tolvaptan unlike aggressive loop diuretic therapy may activate neurohormonal system decrease renal blood flow . These property may make tolvaptan useful addition diuretic therapy prevent renal dysfunction high-risk patient . Therefore primary objective study determine use tolvaptan combination diuretic therapy may prevent development renal dysfunction high risk patient heart failure . Hypothesis : Administration tolvaptan combination continuous loop diuretic therapy acutely decompensated heart failure patient high risk develop diuretic induced renal dysfunction low proportion patient increase serum creatinine &gt; 0.3 mg/dL within 96 hour time frame compare patient receive standard care continuous infusion diuretic .</brief_summary>
	<brief_title>The Use Tolvaptan Prevent Renal Dysfunction High Risk Patients With Heart Failure-Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Tolvaptan</mesh_term>
	<criteria>≥ 18 year old Prior clinical diagnosis systolic heart failure ( EF &lt; 40 % within past 18 month ) daily home use oral loop diuretic least one month . Daily oral dose furosemide ≥ 40 mg ≤ 240 mg ( equivalent ) Identified within 24 hour hospital admission Heart failure define least 1 symptom ( dyspnea , orthopnea , edema ) AND 1 sign ( rales auscultation , peripheral edema , ascites , pulmonary vascular congestion chest radiography ) Anticipated need IV loop diuretic least 48 hour Likely require daily net urine output range 13 L/day 7296 hour time period . Albumin level &lt; 3.5 g/dL Willingness provide inform consent Received plan IV vasoactive treatment ( inotropes , vasodilator ) ultrafiltration therapy heart failure BNP &lt; 250 ng/ml NTproBNP &lt; 1000 mg/ml ( drawn clinical purpose ) Systolic BP &lt; 90 mmHg Serum creatinine &gt; 3.0 mg/dl baseline renal replacement therapy creatinine clearance &lt; 10 mL/min Serum sodium &gt; 145 mEq/L Acute coronary syndrome within 4 week Anticipated need coronary angiography procedure require IV contrast . Patients receive follow drug : clarithromycin , ketoconazole , itraconazole , ritonavir , indinavir , nelfinavir , saquinavir , nefazodone , telithromycin , erythromycin , fluconazole , aprepitant , diltiazem , verapamil , cyclosporine , grapefruit juice . Pregnant nursing patient .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>